Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-8,107
Closed -$541K 276
2021
Q2
$541K Sell
8,107
-307
-4% -$20.5K 0.11% 142
2021
Q1
$626K Buy
+8,414
New +$639K 0.14% 110
2018
Q1
Sell
-57,398
Closed -$2.45M 121
2017
Q4
$2.45M Sell
57,398
-252
-0.4% -$10.1K 0.48% 71
2017
Q3
$2.12M Buy
+57,650
New +$2.33M 0.43% 81
2016
Q4
Sell
-70,567
Closed -$2.74M 139
2016
Q3
$2.74M Buy
+70,567
New +$2.66M 0.61% 56

Other funds holding HOLX

Strategy Asset Managers's HOLX Position: Q3 2021 in Review

Strategy Asset Managers sold out of Hologic (HOLX) in Q3 2021, closing a stake of 8,107 shares — an estimated $541K sold.

Strategy Asset Managers first reported a position in HOLX in Q3 2016 and held it in 5 quarters. The position peaked at $2.74M in Q3 2016. 644 funds tracked by Wall St. Rank hold HOLX as of Q3 2021.

  • Strategy Asset Managers reported no remaining Hologic position as of Q3 2021 after selling out during the quarter.
  • Strategy Asset Managers sold 8,107 Hologic shares in Q3 2021, an estimated $541K.
  • Strategy Asset Managers first reported a position in Hologic in Q3 2016 and held it in 5 quarters.
  • Strategy Asset Managers's Hologic position peaked at $2.74M in Q3 2016.
  • 644 funds tracked by Wall St. Rank held Hologic as of Q3 2021.

Based on Strategy Asset Managers's 13F filing for Q3 2021, filed 14 Dec 2021.